Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elanco Animal Health Inc (ELAN)

Elanco Animal Health Inc (ELAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elanco Animal Health Inc 450 ELANCO CIRCLE INDIANAPOLIS IN 46221 USA

www.elanco.com Employees: 9,000 P: 877-352-6261

Sector:

Medical

Description:

Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.

Key Statistics

Overview:

Market Capitalization, $K 12,724,662
Enterprise Value, $K 16,577,662
Shares Outstanding, K 496,863
Float, K 492,441
% Float 99.11%
Short Interest, K 23,122
Short Float 4.65%
Days to Cover 4.89
Short Volume Ratio 0.40
% of Insider Shareholders 0.89%
% of Institutional Shareholders 97.48%

Financials:

Annual Sales, $ 4,439 M
Annual Net Income, $ 338,000 K
Last Quarter Sales, $ 1,137 M
Last Quarter Net Income, $ -34,000 K
EBIT, $ 687,000 K
EBITDA, $ 1,349 M

Growth:

1-Year Return 126.03%
3-Year Return 95.05%
5-Year Return -14.92%
5-Year Revenue Growth 44.55%
5-Year Earnings Growth -14.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.19 on 11/05/25
Next Earnings Date 02/24/26 [BMO]
Earnings Per Share ttm 0.96
EPS Growth vs. Prev Qtr -26.92%
EPS Growth vs. Prev Year 46.15%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ELAN Ratios

Ratio
Price/Earnings ttm 25.86
Price/Earnings forward 24.44
Price/Earnings to Growth 3.71
Return-on-Equity % 7.41%
Return-on-Assets % 3.64%
Profit Margin % 7.61%
Debt/Equity 0.60
Price/Sales 2.79
Price/Cash Flow 11.02
Price/Book 1.83
Book Value/Share 13.58
Interest Coverage 3.08
60-Month Beta 1.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar